Alex Krauthammer

Dr. Alex Krauthammer


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
AKAlex Krauthammer
Alex Krauthammer
THTal Harel
Tal Harel
NZNoam Zevit
Noam Zevit
DSDror S. Shouval
Dror S. Shouval
RSRaanan Shamir
Raanan Shamir
BWBatia Weiss
Batia Weiss

4 June 2018 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
AKAlex Krauthammer
Alex Krauthammer
ALAvishay Lahad
Avishay Lahad
LGLior Goldberg
Lior Goldberg
ISIfat Sarouk
Ifat Sarouk
BWBatia Weiss
Batia Weiss
IPItai M. Pessach
Itai M. Pessach
Ataxia telangiectasia (AT) is a rare, multi-systemic, genetic disorder. Mutations in the ATM gene cause dysfunction in cell-cycle, apoptosis and V (D) J recombination leading to neurodegeneration, cellular, humoral immunodeficiencies and predisposition to malignancies. Previous studies have suggested that a sub-group of AT patients with elevated IgM levels have a distinct and more severe phenotype. In the current study we aimed to better characterize this group of patients. We performed a retrospective review of 46 patient records, followed from January 1986 to January 2015 at the Israeli National AT Center. Demographic, clinical, radiological, laboratory data was reviewed and compared between AT patients with elevated IgM levels (EIgM) and patients with normal IgM levels (NIgM). 15/46(32.6%) patients had significantly elevated IgM levels. This group had a unique phenotype characterized mainly by increased risk of infection and early mortality. Colonization of lower respiratory tract with Mycobacterium gordonae and Pseudomonas aeruginosa as well as viral skin infections were more frequent in EIgM patients. Patients with NIgM had a significantly longer survival as compared to patients with EIgM but had an increased incidence of fatty liver or cirrhosis. T-cell recombination excision circles and kappa-deleting element recombination circle levels were significantly lower in the EIgM group, suggesting an abnormal class switching in this group. EIgM in AT patients are indicative of a more severe phenotype that probably results from a specific immune dysfunction. EIgM in AT should be considered a unique AT phenotype that may require different management.

16 March 2021 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
AKAlex Krauthammer
Alex Krauthammer
AGAnat Guz‐Mark
Anat Guz‐Mark
NZNoam Zevit
Noam Zevit
LMLuba Marderfeld
Luba Marderfeld
OWOrith Waisbourd‐Zinman
Orith Waisbourd‐Zinman
RSRaanan Shamir
Raanan Shamir

1 March 2023 in Frontiers in Pediatrics
Verified
Journal Article
Open access
AKAlex Krauthammer
Alex Krauthammer
IWIlana Weintraub
Ilana Weintraub
RSRon Shaoul
Ron Shaoul
RLRaffi Lev-Tzion
Raffi Lev-Tzion
EBEfrat Broide
Efrat Broide
BWBatia Weiss
Batia Weiss
Objective and aim: Infantile-onset inflammatory bowel disease (IO-IBD), defined as IBD diagnosed at age 2 years or younger, tends to be more severe and refractory to conventional treatment than IBD diagnosed at a later age. However, data about IO-IBD and its long-term follow up are limited. We thus aimed to evaluate the presentation and long-term outcomes of patients with IO-IBD in a retrospective multicenter study.Methods: Medical records of patients diagnosed with IO-IBD in eight medical centers during 2000–2017 with at least 1-year follow up were reviewed. Demographics and disease characteristics at diagnosis including age of onset, disease phenotype and location, surgeries, medical therapy, and comorbid conditions were recorded.Results: Twenty-three patients with IO-IBD (16 males, 70%) were identified and followed for a median (range) of 51.2 (26.0–110.3) months. The mean ages at presentation and at the last follow up were 14 ± 9.8 and 101 ± 77 months, respectively. Six (26%) patients needed ileostomy already at the time of diagnosis and 20 (87%) were treated with corticosteroids. During long-term follow up, remission was achieved in 16 (73%) patients; of whom, 3 (14%) were without medications and 7 (32%) were in remission with the use of 5-aminosalicylic acid only. One patient needed hemicolectomy and one developed a severe EBV related infection.Conclusion: The majority of patients with IO-IBD achieved long-term remission, despite a severe disease presentation at diagnosis. Surgery rate however is high, mainly during the first months from diagnosis.

11 February 2025 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Open access
AKAlex Krauthammer
Alex Krauthammer
AGAnat Guz‐Mark
Anat Guz‐Mark
NZNoam Zevit
Noam Zevit
OWOrith Waisbourd‐Zinman
Orith Waisbourd‐Zinman
YMYael Mozer‐Glassberg
Yael Mozer‐Glassberg
RSRaanan Shamir
Raanan Shamir
Objectives: Celiac disease (CeD) requires long‐term follow. The role of laboratory testing other than celiac serology during follow up is unclear. We aimed to determine which laboratory tests are required during follow up based on the prevalence of abnormal tests and timing of abnormalities appearance.Methods: Retrospective chart‐review of children diagnosed with CeD between 1999 and 2018 was conducted. Demographic, clinical and laboratory data were recorded from diagnosis and during follow‐up.Results: The cohort included 500 children with CeD [59.8% females, median(IQR) age at diagnosis 5.7(3.7–8.9) years]. Mean follow‐up time was 5.5 years (range 1.5–16.2). The most frequently abnormal laboratory tests at time of diagnosis were low ferritin (64.3%), vitamin D (33.6%), zinc (29.9%), hemoglobin (29.2%), and folate (14.7%). In 74 (14.8%) patients, anemia developed only during follow up, while in another 46 patients, anemia resolved after diagnosis and reappeared later (after a mean ± SD 2.8 ± 2.1 years from CeD diagnosis, for the entire group). Abnormal values that developed during follow up were low folate in 40 patients (3.9 ± 2.6 years), and abnormal liver enzymes in 18 patients (3.1 ± 2.7 years). Elevated TSH during follow‐up was observed in 14/280 (5%) patients, after a mean ± SD of 2.2 ± 1.6 years from diagnosis. Patients diagnosed as teenagers (12–18 years) had shorter intervals to reappearance of anemia and folate deficiency.Conclusions: Multiple laboratory abnormalities may occur in pediatric patients with CeD, both at diagnosis and during long‐term follow‐up. We suggest continued monitoring of hemoglobin, ferritin, folate, liver, and thyroid function in addition to celiac serology during follow‐up of CeD.

6 November 2025 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
AKAlex Krauthammer
Alex Krauthammer
TBTal David Berger
Tal David Berger
NNNurit Nachum
Nurit Nachum
MGMaya Granot
Maya Granot
IBIris Barshack
Iris Barshack
BWBatia Weiss
Batia Weiss